QuidelOrtho (QDEL) has been upgraded to a Zacks Rank #2 (Buy) due to upward revisions in earnings estimates; the Zacks Consensus Estimate for fiscal year 2025 has increased by 4.6% over the past three months. The Zacks rating system, which focuses on earnings estimate revisions, has historically shown a strong correlation with near-term stock price movements, suggesting potential upside for QDEL. The upgrade implies an improved earnings outlook, potentially driving institutional investor interest and subsequent price appreciation.
QuidelOrtho (QDEL) has received an upgraded Zacks Rank #2 (Buy), a development primarily attributed to positive revisions in its earnings estimates, which the Zacks methodology identifies as a significant driver of near-term stock price movements. Over the past three months, the Zacks Consensus Estimate for QDEL's earnings per share for the fiscal year ending December 2025 has risen by 4.6% to $2.39 per share; however, this $2.39 EPS projection is currently unchanged compared to the company's reported earnings for the previous year. The Zacks Rank system, which has an externally-audited track record where its #1 ranked stocks have historically generated an average annual return of +25% since 1988, suggests that such upward revisions in earnings potential often precede stock price appreciation due to increased institutional investor interest. This upgrade positions QuidelOrtho within the top 20% of stocks covered by Zacks in terms of positive earnings estimate revisions, implying an improvement in the company's underlying business fundamentals and a potentially favorable outlook for its stock price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment
